Skip to main content

Table 1 Associations between CCND1 amplification status, cyclin D1 protein expression and clinicopathological variables in all patients

From: Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

All patients

Cyclin D1 cytoplasmic intensity (negative/low, intermediate, high)

Cyclin D1 nuclear intensity (negative/low, intermediate, high)

Cyclin D1 nuclear fraction (< 1%,1 to 9%, 10 to 32%, 33 to 67%, > 67%)

Tumour grade (well, moderate, poor)

Tumour sizea (mm)

Nodal status (negative, 1 to 3, > 3)

Ki67a

CCND1 amplification

      

   Nonamplified

12%, 52%, 36%

40%, 36%, 24%

10%, 24%, 27%, 24%, 15%

23%, 61%, 16%

18.0

70%, 23%, 7%

4.0

   Amplified

6%, 48%, 46%

9%, 35%, 56%

0%, 6%, 18%, 32%, 44%

9%, 62%, 29%

19.0

64%, 26%, 10%

7.5

 

Armitage (P = 0.063)

Armitage (P < 0.001)

Armitage (P < 0.001)

Armitage (P < 0.001)

Wilcoxon (P = 0.083)

Armitage (P = 0.341)

Wilcoxon (P < 0.001)

Cyclin D1 cytoplasmic intensity

      

   Negative/low

 

74%, 16%, 10%

23%, 33%, 26%, 11%, 4%

26%, 59%, 15%

17.5

68%, 24%, 8%

3.2

   Intermediate

 

40%, 36%, 24%

10%, 24%, 27%, 25%, 14%

17%, 63%, 20%

19.0

64%, 34%, 2%

4.6

   High

 

20%, 43%, 37%

3%, 16%, 25%, 28%, 28%

23%, 61%, 16%

17.0

74%, 20%, 6%

5.6

  

Goodman = 0.44 (P < 0.001)

Goodman = 0.39 (P < 0.001)

Goodman = -0.06 (P = 0.238)

Cuzick trend (P = 0.010)

Goodman = -0.12 (P = 0.031)

Cuzick trend (P = 0.021)

Cyclin D1 nuclear intensity

      

   Negative/low

  

23%, 33%, 26%, 11%, 4%

24%, 62%, 14%

18.0

67%, 25%, 8%

2.9

   Intermediate

  

1%, 12%, 41%, 36%, 10%

18%, 65%, 17%

18.0

68%, 25%, 7%

4.8

   High

  

0%, 1%, 7%, 37%, 55%

17%, 59%, 24%

17.5

71%, 22%, 7%

6.3

   

Goodman = 0.88 (P < 0.001)

Goodman = 0.16 (P < 0.001)

Cuzick trend (P = 0.553)

Goodman = -0.05 (P = 0.327)

Cuzick trend (P < 0.001)

Cyclin D1 nuclear fraction

      

   < 1%

   

18%, 68%, 14%

20.0

2%, 29%, 9%

2.8

   1 to 9%

   

23%, 62%, 15%

18.0

68%, 25%, 7%

2.7

   10 to 32%

   

24%, 59%, 17%

18.0

71%, 25%, 4%

4.4

   33 to 67%

   

20%, 59%, 21%

18.0

70%, 21%, 9%

4.9

   > 67%

   

12%, 68%, 20%

16.0

68%, 24%, 8%

5.9

    

Cuzick trend (P = 0.005)

Spearman ρ = -0.04 (P = 0.162)

Cuzick trend (P = 0.694)

Spearman ρ = 0.22 (P < 0.001

  1. Tests used: Armitage's trend test, Wilcoxon test, Goodman's test, Spearman correlation test and Cuzick test. aMedian value for each category.